#mifepristone

#mifepristone

Florida and Texas made a quiet move last week that could have huge implications nationwide: Their attorneys general asked to join a federal lawsuit against the Food and Drug Administration that seeks to drastically roll back access to the main abortion drug, mifepristone. The states argue that the medication's FDA approval should be revoked or, failing that, that telemedicine prescriptions should be once again banned. Telehealth has allowed thousands of people to get abortion pills in states where the procedure is prohibited.

The Trump administration's request to dismiss the mifepristone lawsuit appears as a defense of the drug, despite the president's history of rolling back abortion rights.

Our data shows that chemical abortion poses greater risks to women in real-world clinical use than revealed in the clinical trials of mifepristone and that the rate of serious adverse events from the chemical abortion regimen continues to grow in recent years.